These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 558945)

  • 1. [Study of intracranial dynamics by applying a water-soluble contrast medium, N-methylglucamine iothalamate, to the dog brain].
    Wakabayashi K
    Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):37-50. PubMed ID: 558945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dimer-X in the intracranial subarachnoid space--its toxicity (author's transl)].
    Nishikawa M; Yonekawa Y
    No Shinkei Geka; 1976 Jun; 4(6):543-47. PubMed ID: 1087706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic effect of intracranial subarachnoid application of metrizamide and meglumine iocarmate. An experimental investigation in dogs in neurolept analgesia.
    Grepe A; Widén L
    Acta Radiol Suppl; 1973; 335():102-18. PubMed ID: 4534544
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast and electrolyte dynamics of the intravenous pyelogram. II. Disparities in serum and urine concentrations of meglumine and anion.
    Lasser EC; Lang JH; Hamblin AE; Rosen L
    Invest Radiol; 1975; 10(4):307-13. PubMed ID: 1184320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and experimental study of meglumine iocarmate in the subarachnoid space: a complication of positive contrast ventriculography.
    Yonekawa Y; Nishikawa M; Egli M; Klaiber R
    Surg Neurol; 1976 Mar; 5(3):167-70. PubMed ID: 816023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventriculography with methylglucamine iocarmate (Dimer-X). Experimental and clinical study.
    Suzuki S; Kawaguchi S; Mita R; Iwabuchi T
    Acta Neurochir (Wien); 1976; 33(3-4):219-31. PubMed ID: 1085093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate.
    Sage MR; Wilcox J; Evill CA; Benness GT
    AJNR Am J Neuroradiol; 1983; 4(4):893-5. PubMed ID: 6410875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic effects of meglumine iothalamate. Ventriculography in canines.
    Weems TD; Cashion EL; Cunningham DL
    Neuroradiology; 1977 May; 13(3):151-4. PubMed ID: 301255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of water-soluble contrast media from the subarachnoid space. Investigation with computer tomography.
    Hindmarsh T
    Acta Radiol Suppl; 1975; 346():45-9. PubMed ID: 181951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convulsions subarachnoid haemorrhage and death following myelography with meglumine iothalamate 280.
    Bagchi AK
    Surg Neurol; 1976 May; 5(5):285-6. PubMed ID: 1265645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain parenchyma penetration by intrathecal ionic and nonionic contrast media.
    Sage MR; Wilcox J; Evill CA; Benness GT
    AJNR Am J Neuroradiol; 1982; 3(5):481-3. PubMed ID: 6814212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide.
    Skalpe IO
    Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for nitric oxide in X-ray contrast material toxicity.
    Lasser EC; Lamkin GE; Lyon S
    Acad Radiol; 1995 Jul; 2(7):559-64. PubMed ID: 9419605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of metrizamide and meglumine iocarmate after suboccipital injection in rats. Acute and long-term effects.
    Skalpe IO; Torvik A
    Acta Radiol Suppl; 1973; 335():143-52. PubMed ID: 4534547
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of iothalamate meglumine, metrizamide and iodophendylate in cerebral ventriculography. A clinical, radiological and histopathological study in the rat.
    Klee JG; Praestholm J
    Invest Radiol; 1975; 10(3):244-50. PubMed ID: 1079522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ventriculography with methylglucamine iocarmate (Dimer-X). Experimental and Clinical study (author's transl)].
    Suzuki S; Kawaguchi S; Mita R; Ito K; Iwabuchi T
    No Shinkei Geka; 1975 Oct; 3(10):849-58. PubMed ID: 1082558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of blood-brain barrier disruption in the rabbit following intracarotid iopamidol and methylglucamine iothalamate.
    Wycherley AG; Wilcox J; Sage MR
    Australas Radiol; 1984 Nov; 28(4):294-6. PubMed ID: 6535564
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of non-ionogenic contrast media for myelography].
    Sviridov NK; Popova ZP; Varfolomeeva VN
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (4):50-3. PubMed ID: 6388202
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of intracranial pressure of meglumine iothalamate ventriculography.
    Shaw MM; Miller JD; Steven JL
    J Neurol Neurosurg Psychiatry; 1975 Oct; 38(10):1022-6. PubMed ID: 1081586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.